[6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone

C15H23N5O2 — CID 95725216

IUPAC[6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone
SMILESN[C@@H]1CCCN(c2cncc(C(=O)N3CCOCC3)n2)CC1
InChIInChI=1S/C15H23N5O2/c16-12-2-1-4-19(5-3-12)14-11-17-10-13(18-14)15(21)20-6-8-22-9-7-20/h10-12H,1-9,16H2/t12-/m1/s1
InChIKeyOPZWIOHSSYHGED-GFCCVEGCSA-N
MW305.38 g/mol
LogP0.27
Rot. Bonds2

About [6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone

[6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone (PubChem CID 95725216) has the molecular formula C15H23N5O2 and a molecular weight of 305.38 g/mol. Its IUPAC name is [6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone.

Molecular Properties

Compound Name[6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone
PubChem CID95725216
Molecular FormulaC15H23N5O2
Molecular Weight305.38 g/mol
Exact Mass305.19
IUPAC Name[6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone
SMILESN[C@@H]1CCCN(c2cncc(C(=O)N3CCOCC3)n2)CC1
InChIInChI=1S/C15H23N5O2/c16-12-2-1-4-19(5-3-12)14-11-17-10-13(18-14)15(21)20-6-8-22-9-7-20/h10-12H,1-9,16H2/t12-/m1/s1
InChIKeyOPZWIOHSSYHGED-GFCCVEGCSA-N
XLogP0.27
TPSA84.58 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds2
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500305.38
LogP ≤ 50.27
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze [6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

piperidin-1-yl-(6-piperidin-1-ylpyrazin-2-yl)methanone
CID 165345728
[6-[(3R,4R)-3-hydroxy-4-(hydroxymethyl)piperidin-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone
CID 155498445
morpholin-4-yl-[6-(1-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl]methanone
CID 56872166
[6-(2-cyclopropylmorpholin-4-yl)pyrazin-2-yl]-morpholin-4-ylmethanone
CID 131932483
[6-[4-(cyclopropylmethyl)-3-propan-2-yl-1,4-diazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone
CID 56865396
morpholin-4-yl-[6-[(5S)-2-oxa-9-azaspiro[4.5]decan-9-yl]pyrazin-2-yl]methanone
CID 97192527
[6-(3-methyl-3-phenylpiperidin-1-yl)pyrazin-2-yl]-morpholin-4-ylmethanone
CID 72904435
[6-[3-(3-hydroxypropyl)-4-morpholin-4-ylpiperidin-1-yl]pyrazin-2-yl]-pyrrolidin-1-ylmethanone
CID 156606651
(6-chloropyrazin-2-yl)-(1,4-oxazepan-4-yl)methanone
CID 106551253
(5S)-2-[6-(morpholine-4-carbonyl)pyrazin-2-yl]-2,7-diazaspiro[4.5]decan-6-one
CID 97152335
(1S,6R)-9-[6-(morpholine-4-carbonyl)pyrazin-2-yl]-3,9-diazabicyclo[4.2.1]nonan-4-one
CID 50958440
1-[3-[[6-(morpholine-4-carbonyl)pyrazin-2-yl]methyl]piperidin-1-yl]ethanone
CID 110257663

Frequently Asked Questions

What is the IUPAC name of [6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone?
The IUPAC name of [6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone (CID 95725216) is [6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone.
What is the SMILES notation for [6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone?
The canonical SMILES for [6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone is N[C@@H]1CCCN(c2cncc(C(=O)N3CCOCC3)n2)CC1.
What is the InChIKey of [6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone?
The InChIKey is OPZWIOHSSYHGED-GFCCVEGCSA-N. The full InChI is InChI=1S/C15H23N5O2/c16-12-2-1-4-19(5-3-12)14-11-17-10-13(18-14)15(21)20-6-8-22-9-7-20/h10-12H,1-9,16H2/t12-/m1/s1.
What are the key properties of [6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone?
[6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone has a molecular weight of 305.38 g/mol, XLogP of 0.27, 2 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [6-[(4R)-4-aminoazepan-1-yl]pyrazin-2-yl]-morpholin-4-ylmethanone is sourced from PubChem (CID 95725216), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).